chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report was received from a licensed practical nurse referring to a patient of unknown age and gender. There was no concomitant medication. Information about concurrent conditions and medical history was not provided. On 25-APR-2017 at 10:00 am, the last recorded temperature of the vaccines was 4 Celsius degree. On the same day at unspecified time, the ROTATEQ were discovered out of temperature range (refrigerator temperature was 12.7 Celsius degree). The vaccines were not moved to a working refrigerator post the event. It was also reported that the vaccines experienced a temperature excursion during 1 hour 17 minutes. No previous temperature excursion was reported. A data logger issue was involved. On 30-MAY-2017, the patient was vaccinated with improperly stored doses of ROTATEQ (lot number M039067 with expiration date of 18-APR-2018; strength and dose were unknown; location was also reported as "2", dose number was also reported as "0"; Vaccines for Children Program (VFC) stock) orally for prophylaxis. The nurse sated that they would monitor every 30 minutes to insure temperature with range. It was confirmed the vaccines were OK to use. There was no adverse event reported. This is one of several reports received from the same reporter. Additional information has been requested.; Sender's Comments:  US-009507513-1704USA014144:
- Fever, chills / sweating, headache, fatigue, body ache lasting approximately 24 hours in total from onset. Significant symptoms at ~16 hours post-vaccine - Significant lymph node swelling on left side of body (side of vaccine administration) - under left arm, groin, neck in particular are noticeably enlarged and tender to the touch. At 96 hours post-vaccine, small pain still noticeable in enlarged lymph node locations (left groin, under left arm, neck). It does seem to be somewhat improved  day over day (as of this writing, 100 hours post-vaccine) - Chest tightness from approximately 24 hours post vaccine continuing to this writing (100 hours post-vaccine), though unclear if related to mild pain of left underarm lymph swelling or seperate
More than 35 days from first vaccination; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (More than 35 days from first vaccination) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 17-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (More than 35 days from first vaccination). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (More than 35 days from first vaccination) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant drug details were reported. No treatment details were reported.   Most recent FOLLOW-UP information incorporated above includes: On 23-Aug-2021: Follow-up received contains no new information.
Second shot kicked my butt; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of feeling unwell in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Family history included shingles (patient's father had shingles).   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced feeling unwell (Verbatim: Second shot kicked my butt). The outcome of the feeling unwell was resolved (duration 18 hrs).   It was unknown if the reporter considered the feeling unwell to be related to Shingles vaccine.   It was unknown if the company considered the feeling unwell to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 15-MAR-2023 This case was reported by a patient via interactive digital media. The reporter stated that no idea but he/she would said the shingles shot kicked his/her butt for about 18 hours. The reporter further stated that still better than witnessing his/her father had shingles. The follow up would not possible as no contact details were available.
A report was received from a healthcare professional on 06/16/2001, concerning a 20 year old female patient who experienced motor deficiency on the left foot after receiving the Fluvirin vaccine in November 2000. In November 1999, the patient experienced motor deficiency on the left foot after receiving Vaxigrip influenza vaccine and again in November 2000 after receiving Fluvirin vaccine.  The patient recovered in May 2000 and April 2001 respectively. The reporter assessed the relationship of the Vaxigrip influenza vaccine to the event as unclassifiable. The reporter has assessed the relationship of the Fluvirin vaccine to the event as probable.
I woke up on Sunday morning with tingling in my left arm from my shoulder to my fingertips and my right leg by the shin area.  My left ear was itchy and hot to the touch. I took half a Benedryl. I did a telemed visit with my MD about my arm. She ordered a STAT US of my left arm and prescribed me prednisone.
My endometriosis hurt so bad I wanted to die, couldn?t speak, couldn?t move, couldn?t call for help. Would have called 911 if I could have made a telephone call. There is no way to describe the pain if was so bad. I think torture is the only way to compare. I would have done anything, signed anything, chosen death if it made the pain stop.  I lived on 800mg of ibuprofen every 4 hours for three days to bring it down to a ?livable? amount of pain.  Will this happen again next month is my question. I will not get the second shot or any other shots in the future. Would rather die.
Patient immediately felt pain down right arm, pain increased during afternoon.  Patient went to emergency room in evening and received morphine injection.  As of 11-7-2006 in evening symptoms are improving.
Severe pain as soon as flu vaccine was injected in right arm at injection site, with shooting pain in entire right arm. There has been no treatment and severe pain continues. There is difficult and limited movement where there was none before the vaccine. There was no pain in right arm before Vaccine was injected. Pain is also in my right hand now. I can no longer use my hand and arm to do certain things now.
Rec'd Engerix-B on 17OCT90, on 18OCT90 experienced pruritus but no rash. given Benadryl QID 3-4 days. had itching for 3-4 days & then resolved.
Extreme fatigue, body aches ongoing since the day after injection, heart palpitations at night that wake me. Fluttering, and irregular heartbeat. Heightened anxiety.
Pt received 1st Astrazeneca Covid-19 on 05/31/2021 and 2nd dose Astrazeneca Covid-19 on 08/02/2021.  Booster Pfizer on 12/03/2021.  Pt received booster shot before 02/02/2022.   Pt was seen at site and was starting the series over per her MD, no ME evaluation documented or counselled about WHO authorized vaccine or verification of vaccine timing documented.  Pt received Pfizer shot on 12/02/2021 instead of 02/02/2022.
An attorney reported that a male child received Tetramune, ActHib, Engerix B, IPOL, DTP, Tripedia, Attenuvax, HIB, Orimune, and MMR vaccines between the time period of 04/23/1996 to 10/27/1997. It is alleged that, as a result of exposure to these vaccines, he experienced thimerosal-induced mercury poisoning. Mercury poisoning is considered medically important. The reporter indicated that Orimune lot 70360 administered; however, this is not a valid manufacturer lot number.
Flu shot was received at a benefits fair held at the college I work for.  During the evening I started feeling dizzy, especially if I tried to focus on something in the distance.  Also lightheaded.  When I laid down to sleep I felt like I had vertigo, the room spinning.  During the night I woke up with chills and was achy.  By the morning the symptoms improved, but it wasn't until the evening of Oct. 15th when I again felt normal.
Pt. states that after receiving the 1st dose of Pfizer 08/06/2021, started experiencing symptoms 08/07/2021 of severe left leg pain, difficulty walking (lasting a week), and moving through both legs. Urgent Care visit 08/09/2021, muscle spasms Ultrasound (no blood clots found). 7 days symptoms have subsided.
I have noticed considerable joint pain since my second vaccine. I do not really remember the exact date as initially I didn't think anything about a connection to the vaccine. However, that was the only thing that was different. Since then I have been hearing many of our patients talking about having joint pains that began sometime after their second COVID vaccine and have continued for weeks to even months so that made me think that this could possibly be why I am having such joint pains all over that I haven't had before.
PAIN IN  LEFT ARM; HEADACHE; SWOLLEN LEFT ARM/LEFT ARM IS PRETTY SWOLLEN; COLD SWEAT; NECK PAIN; BACK PAIN; LEG PAIN; CHILLS; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 201A21A, expiry: UNKNOWN) dose was not reported, administered on 10-APR-2021 10:00 for prophylactic vaccination. No concomitant medications were reported. On APR-2021, the subject experienced chills. On APR-2021, the subject experienced cold sweat. On APR-2021, the subject experienced leg pain. On APR-2021, the subject experienced headache. On APR-2021, the subject experienced back pain. On APR-2021, the subject experienced swollen left arm. On APR-2021, the subject experienced neck pain. On 10-APR-2021, the subject experienced pain in left arm. Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the pain in left arm, chills, cold sweat, leg pain, headache, back pain, swollen left arm and neck pain was not reported. This report was non-serious.
Seizure like activity at 6:30pm, high fever, unable to speak or communicate, eyes closed. Called 911, taken to hospital via ambulance. Admitted to ER with cognitive deficits, admitted to neuroscience overnight.
Chilled, shaking uncontrollably. EMT's called. Pt was not transported. Felt very ill, both arms were sore.
Subsequent to receiving one dose of varicella virus vaccine live the pt experienced chickenpox on the neck, back, and scalp accompanied by a fever. The pt was also cranky and itchy.
Narrative:  patient developed immediate reaction following 2nd dose of Pfizer Covid vaccine. Patient began to shake, developed shortness of breath, and throat felt funny. Patient took epi-pen that her husband carried for her from the allergist. Patient has no history of asthma or hypoxia. Patient was hypertensive and tachycardia, throat was "numb" and patient had hives that developed under the blood pressure cuff.
This spontaneous report as received from a medical assistant refers to a unspecified number of patients of unknown age and gender. Medical history and concurrent conditions were not reported. On an unknown date in 2015, since 26-FEB-2015, the patients were vaccinated with improperly stored PEDVAXHIB (dose, route, lot number and expiration date were not reported). No adverse effects reported. This is one of several reports from the same source. Additional information has been requested.
The patient developed a pulmonary embolism three days after the second dose, shortness of breath, hypotension, tachycardia.
pt recv vax 17OCT96 & 20OCT96 pt exp fever, nausea, chang in taste, malaise;seen 28OCT96;SGOT 348, SGPT 538 w/nl t. bili; & alk 0;negative hep A,B,C, monospot, EBVAB, CMVAb, toxo Ab;
Intense abdomen, side, and back muscle cramping/contractions. Trouble breathing due to intense muscle cramping. Difficult to move. A heating pad was used to relax the muscles, but the cramping lasted about an hour. Ibuprofen was taken to relieve muscle cramping.
Broke out in hives 24-36 hr after shots - closer to 36 hr. Still acting ok. Hives still present 4 days later with no fever. Pt never uncomfortable, never received Benadryl. Hives more concentrated on abdomen.
DOB REPORTED AS 06/30/2009 ON CONSENT BUT ACTUAL DOB IS 06/30/2010. VACCINATED UNDERAGED.
This case was reported by a nurse via other manufacturer and described the occurrence of swallowing difficult in a patient who received ROTARIX. Previously administered products included ROTARIX vaccine (1st dose received on an unknown date). On an unknown date, the patient received the 2nd dose of ROTARIX. On an unknown date, unknown after receiving ROTARIX, the patient experienced swallowing difficult. On an unknown date, the outcome of the swallowing difficult was unknown. It was unknown if the reporter considered the swallowing difficult to be related to ROTARIX. Additional details were provided as follows: The patient received 2 doses of ROTARIX and subsequently had a gastrostomy tube (g-tube) placed. The lot number and expiration date was unknown. The reporter stated that the patient was having difficulty swallowing. No further information was provided.
received 1st dose of Pfizer vaccine in left arm, developed  tender, painful 3cm lymph node in left axilla on day 5  (12/27/20)
Kawasaki disease: vaccines May 9th 2006 - May 10th Fever that lasted >7 days (high fever). Ectasia of coronary arteries/ red lips/ blistering. Received IVIG as a result. Followed by cardiology and Kawasaki Team at hospital. 8/9/06 Received medical records from hospital & clinic which reveal patient was previously healthy twin who became ill with fever 1 day s/p vax.  Persisted daily up to 105.  Twin sister had also developed fever on day of vax & was cultured. all of which were neg & following day she defervesced.  Patient continued w/fever & developed URI symptoms including rhinorrhea, cough & congestion with emesis & diarrhea developing.  Was cultured on day 3.  Received IM antibiotics but developed dry cracked lips w/blisters which progressed.  Symptoms along with echocardiogram led to dx of Kawasaki disease.  Admitted for IVIG & ASA therapy.  Improved & was d/c to home to continue with daily ASA & f/u with cardiology & PCP/ss
Fatigue; Injection site pain; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2), administered in arm, administration date 25Oct2021 (Lot number: FH8020) as dose 3 (booster), single for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included: TRI LO MARZIA (ongoing). Vaccination history included: Bnt162b2 (Dose number: 1, Anatomical site of injection: Arm, Batch/lot number: EL3247, Resolved within 24 hours with no further action taken, no medication used), administration date: 01Mar2021, for COVID-19 immunization, reaction(s): "pain was in the arm of vaccine injection"; Bnt162b2 (Dose number: 2, Anatomical site of injection: Arm, Batch/lot number: EP6955, Resolved within 24 hours with no further action taken, no medication used), administration date: 24Mar2021, for COVID-19 immunization, reaction(s): "pain was in the arm of vaccine injection". The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 25Oct2021 20:00, outcome "recovered" (26Oct2021), described as "Injection site pain"; FATIGUE (non-serious) with onset 26Oct2021, outcome "recovered" (26Oct2021), described as "Fatigue". Therapeutic measures were not taken as a result of vaccination site pain, fatigue.  Follow-up attempts completed. No further information expected.
On the 9th day following my first vaccine that morning I started to feel tired, it then followed by body aches and chills. I then developed fever up to 101.3. This lasted for two days. The day symptoms started was New Years Eve and the clinics were closed and closed on New Years Day so on Jan 2 Saturday I reported to Urgent Care to get tested for Covid.
Evening of the same date of vaccination patient developed fever over 102 degrees, arm pain, night sweats, chills, body aches & felt like "he had been hit with a baseball bat". Recovered 3 days later and was able to return to work.
Severe headache as similar to the one which the patient had when he was positive for covid; Chills; Fever; Weakness; A spontaneous report (US) was received from a 71-years-old male consumer, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced severe headache as similar as the one he had when he was positive for Covid, also had chills, fever up to 102F and felt weakness.  The patient's medical history was not provided. The patient was taking heart medications concomitantly.   On 20-JAN-2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (lot/batch: D13L20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.  On 20-JAN-2021, the patient experienced severe headache as similar as the one he had in August2020 when he was positive for Covid, that lasted till 23Jan2021, also had chills, fever up to 102F and felt weakness till 23Jan2021.  The patient had fever upto 102 F  from 20-JAN-2021 till 23-JAN-2021.  The patient took Tylenol from 20-JAN-2021 to 23-JAN-2021, to subside the symptoms.   Action taken with mRNA-1273 in response to the events was not reported.  The outcome of the events was recovered/resolved.
DATE OF ADMISSION:  05/19/2023 DATE OF DISCHARGE:  05/24/2023 Hospital  PROVISIONAL DIAGNOSES 1. Sepsis. 2. COVID-19, asymptomatic. 3. High-grade B-cell lymphoma. 4. History of follicular lymphoma. 5. Nausea, vomiting. 6. Hypovolemic hyponatremia. 7. Hypogammaglobulinemia. 8. History of asthma. 9. Gastroesophageal reflux disease. 10. Dyslipidemia.   DISCHARGE DIAGNOSES 1. Sepsis secondary to Escherichia coli bacteremia. 2. Asymptomatic COVID-19. 3. High-grade B-cell lymphoma with progression. 4. Follicular lymphoma. 5. Headaches. 6. Hypogammaglobulinemia. 7. Hyponatremia. 8. Hypertension. 9. History of asthma. 10. Pancytopenia with neutropenia. 11. Gastroesophageal reflux disease. 12. Dyslipidemia.   CONDITION ON DISCHARGE Stable.   PROCEDURES PERFORMED None.   CONSULTATIONS Infectious Disease.   HOSPITAL COURSE The patient is a very pleasant 77-year-old female with past medical history as listed above including high-grade B-cell lymphoma with antecedent follicular lymphoma, status post CAR-T cell therapy in July 2022, on 4th line Revlimid and Monjuvi, who presented initially to our Same-Day Clinic with nausea, vomiting, then the following morning awoke with chills and fever of 101.  She had an outpatient PET scan the morning of admission that did not show obvious source for her fever, but did suggest progression of disease.  The patient was leukopenic, neutropenic, tachycardic, febrile on presentation.  Blood cultures were obtained on 05/19 and grew E coli.  Chest x-ray showed right lower lobe perihilar pneumonia.  The patient was asymptomatic.  UA with few bacteria and nitrites suggestive of UTI.  Urine culture was positive for E coli.  FilmArray was positive for COVID but cycle threshold was 24.7.  She was started on cefepime and Zithromax.  This was transitioned to Zosyn.  Infectious Disease was consulted to deescalate antibiotics to Rocephin.  Repeat UA was negative.  ID recommended transitioning to oral Bactrim DS 2 tabs b.i.d. to complete a 7-day course with end of therapy May 27.  The patient recently tested positive for COVID in March of 2023 and was asymptomatic at that time.  Again, her cycle threshold with this positive result was 24.7.  No therapy was indicated at this time per Infectious Disease and they recommended continuing supportive care.  Again, her PET-CT overall showed significant progression of disease.  Malignant Hematology attending reviewed prognosis and available palliative options including possible clinical trial and loncastuximab.  We will arrange followup with Dr. in a couple of weeks as an outpatient to further discuss.  She did receive IVIG on May 21 while hospitalized with a serum IgG level of 261.  Nausea, vomiting had resolved.  Overall, she did well during the course of the hospital stay and was felt medically stable for discharge to home on 05/24/2023.
This case was reported by a healthcare professional and described the occurrence of a medication error in a 52-year-old female subject who was vaccinated with Flulaval (GlaxoSmithKline).  On 28 August 2007 at 15:00 the subject received 1st dose of Flulaval at 0.5 ml in the right arm.  On 28 August 2007, immediately following vaccination with Flulaval, it was noted that the vaccine given was from the past flu season (2006-2007).  This was considered to be a medication error.  The subject also developed injection site redness and swelling on 28 August 2007.  At the time of reporting the medication error was unresolved.  In the reporter's opinion, the events were probably related to treatment with Flulaval.
Chills; Low grade fever; Nausea; Pain; Swollen lymph nodes in armpit; This is a spontaneous report from a contactable Healthcare Professional (patient).This 42- year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE Lot number: lot EL3246), via an Intramuscular route of administration, on 06Jan2021 09:15AM (at the age of 42-years-old) as a single dose for COVID-19 vaccination. The facility where COVID-19 vaccine was administered was at a hospital and anatomically located on the left arm. The patient did not have any allergies to medications, food, or other products. Medical history included: Mitral valve prolapse.  Concomitant medications were not reported.  The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE Lot number: lot EH9899) via an Intramuscular route of administration, on 18Dec2020 at 03:30 PM (at the age of 42-years-old) as a single dose for COVID-19 vaccination, anatomically located on the right arm. The patient was not pregnant at the time of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Jan2021 at 01:30 AM, she experienced chills, low grade fever, nausea, pain, and swollen lymph nodes in armpit. The patient did not receive treatment for the events. The clinical outcome of the events chills, low grade fever, nausea, pain, and swollen lymph nodes in armpit was recovering. It was also reported that since the vaccination, the patient had not been tested for COVID-19.  No follow-up attempts are possible. No further information is expected.
Three-month bout with SHINGLES. On July 15, 2020, a nickel-sized sore appeared on the right side of my neck.  There was only one during the three months, BUT within a few days, I started experiencing severe pain up the side of my head, and down my neck.  My skin became very sensitive to touch.  In a week, my doctor diagnosed it as shingles, and he gave me Gabapenton for pain, sterodal medicine, and apills for a virus infection.  After the three months of severe exhaustion and pain, I began to recover and now six months later, I believe I have fully recovered, fortunately without any long-term effects (although, for 2 days I suffered Bells Palsy. and for two weeks I had double vision.)